| Name | Title | Contact Details |
|---|
At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.
Concentra Managed Care, Inc. is the leading provider of healthcare management and cost containment services to the workers' compensation, auto insurance and disability insurance markets.
Treatment Solutions Network is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Award winning martial arts. RealFit4Life Building, Bressi Ranch Carlsbad. Accredited with the Traditional Tang Soo Do Federation. Dedicated to our community.
Nuvem integrates comprehensive and compliant pharmacy solutions with clinical care to increase access to affordable drugs, improve patient outcomes, and optimize financial results for healthcare providers.